Patients News | pharmaphorum

News

Pazdur to leave FDA, shortly after taking CDER job

Long-serving FDA figure Richard Pazdur has filed papers to retire, shortly after being appointed to lead CDER, according to reports.

News

Bayer aims Mirena at women's health issue with no treatment

Bayer has started a phase 3 trial of its Mirena contraceptive in an endometrial disorder, with no treatments, that can lead to cancer.

News

Female HCP talks to female patient sat on examination table

Slow recruitment still hitting UK trials, says pharma

Despite efforts to improve the environment for UK clinical trials, the sector is still facing headwinds like low recruitment rates and rising costs.

News

US and UK flags side by side blending into each other

UK and US agree zero tariffs on pharma – with price rises

A deal between the UK and the US will maintain tariffs on imports into the US at 0%, but prices of medicines used by the NHS will go up.

News

Real-world trial of Lilly's tirzepatide starts in UK

A real-world study exploring the long-term effects of Eli Lilly's weight-loss therapy tirzepatide in primary care settings has started in the UK.

News

Is FDA about to restrict vaccination even further?

Vinay Prasad, head of CBER, is reported to be planning to tighten regulations on vaccines after concluding that COVID-19 shots caused 10 child deaths.

Pazdur to leave FDA, shortly after taking CDER job

Bayer aims Mirena at women's health issue with no treatment

Slow recruitment still hitting UK trials, says pharma

UK and US agree zero tariffs on pharma – with price rises

Real-world trial of Lilly's tirzepatide starts in UK

Is FDA about to restrict vaccination even further?

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

News

Editor's Picks